November 18th, 2019 | 11:43 CET
BIGG DIGITAL ASSETS, NEL ASA, NOXXON PHARMA AND RYU APPAREL - THE PRICE POTENTIAL OF PENNY STOCKS
Table of contents:
Born and raised in Hannover, Lower Saxony follows social and economic developments around the globe. As a passionate entrepreneur and columnist he explains and compares the most diverse business models as well as markets for interested stock traders.
WHEN BLOCKCHAIN WAS STILL SEXY
BIGG Digital Assets from Canada is focused on the blockchain sector. The company has positioned itself in this area in recent years and was able to collect around CAD 20 million from investors in connection with the blockchain hype around two years ago to build up the product universe. The highest capital increase was successfully carried out at CAD 0.75 in December 2017. Subsequently, the shares changed hands under the former name BIG Blockchain Intelligence Group to CAD 2.77.
On Friday, the share was trading at CAD 0.04 and at an historically low level. The company had recently published success reports and still had CAD 8.28 million cash in its account as per June 30, 2019. The market value on Friday was CAD 6.44 million. Should the interest in blockchain technologies rise again sometime, then this share can probably become a high performer.
IN THE CENTER OF THE HYPES
NEL ASA is a penny stock company from Norway and is one of the most discussed shares this year. The reason is easy to understand. The company develops and manufactures plants for the production of hydrogen and in connection with the change in mobility, the investment community is currently lacking competition for financial commitments. The company's share was traded around 12 months ago at less than EUR 0.42 and most recently at EUR 0.85. The market value of NEL ASA is currently EUR 1.02 billion.
As of September 30, 2019, the company generated a loss of around EUR 17 million in the first nine months of the current financial year. The cash position still contained around EUR 65 million cash. Due to the hypes surrounding hydrogen, it can be assumed that the company can currently tap the capital market again at any time in order to secure its continued existence - but this was also thought at BIG two years ago.
SUCCESS WITHOUT RECOGNITION
NOXXON Pharma from Berlin operates as a Dutch company form NV on the stock exchange and therefore has the possibility to issue shares below the price of EUR 1.00 within the scope of equity financing. The company is active as a biotech company in cancer research and has already made progress with developed preparations in various forms of therapy.
NOXXON is a classic takeover candidate as soon as one of the large pharmaceutical companies recognizes an opportunity to turn the research results of the Berlin-based company into money. The value of the share is currently traded at around EUR 0.35 and thus has a market capitalization of around EUR 5 million.
FASHION LABLE WITH SPORTY PRICE POTENTIAL
The Canadian fashion label RYU Apparel has invested a lot of money in the development of the brand in recent years and has been able to show interesting growth rates. The company has financing needs and for this reason the price per share can be an attractive entry opportunity for experienced fashion experts with deep pockets.
The company's sporty line is available in stores in various metropolises in Canada and the USA - and online shops. Once a financing round has been completed, the share may have turnaround potential. Most recently, the shares changed hands at CAD 0.03 and the company has a market capitalization of CAD 17.5 million.
Conflict of interest
Pursuant to §85 of the German Securities Trading Act (WpHG), we point out that Apaton Finance GmbH as well as partners, authors or employees of Apaton Finance GmbH (hereinafter referred to as "Relevant Persons") may in the future hold shares or other financial instruments of the mentioned companies or will bet on rising or falling on rising or falling prices and therefore a conflict of interest may arise in the future. conflict of interest may arise in the future. The Relevant Persons reserve the shares or other financial instruments of the company at any time (hereinafter referred to as the company at any time (hereinafter referred to as a "Transaction"). "Transaction"). Transactions may under certain circumstances influence the respective price of the shares or other financial instruments of the of the Company.
Furthermore, Apaton Finance GmbH reserves the right to enter into future relationships with the company or with third parties in relation to reports on the company. with regard to reports on the company, which are published within the scope of the Apaton Finance GmbH as well as in the social media, on partner sites or in e-mails, on partner sites or in e-mails. The above references to existing conflicts of interest apply apply to all types and forms of publication used by Apaton Finance GmbH uses for publications on companies.
Apaton Finance GmbH offers editors, agencies and companies the opportunity to publish commentaries, interviews, summaries, news and etc. on news.financial. These contents serve information for readers and does not constitute a call to action or recommendations, neither explicitly nor implicitly. implicitly, they are to be understood as an assurance of possible price be understood. The contents do not replace individual professional investment advice and do not constitute an offer to sell the share(s) offer to sell the share(s) or other financial instrument(s) in question, nor is it an nor an invitation to buy or sell such.
The content is expressly not a financial analysis, but rather financial analysis, but rather journalistic or advertising texts. Readers or users who make investment decisions or carry out transactions on the basis decisions or transactions on the basis of the information provided here act completely at their own risk. There is no contractual relationship between between Apaton Finance GmbH and its readers or the users of its offers. users of its offers, as our information only refers to the company and not to the company, but not to the investment decision of the reader or user. or user.